Tech Company Financing Transactions
AnaptysBio Funding Round
AnaptysBio closed a $860.5 thousand financing round on 11/16/2010. Backers included private investors.
Transaction Overview
Company Name
Announced On
11/16/2010
Transaction Type
Venture Equity
Amount
$860,482
Round
Undisclosed
Investors
Proceeds Purpose
Funding has been awarded for four product programs, including the company's differentiated anti-IL17 monoclonal antibody (mAb) program.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10421 Pacific Center Ct. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
AnaptysBio (NASDAQ: ANAB) is a leading biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hamza Suria
Chief Financial Officer
Eric Loumeau
Chief Medical Officer
Marco Londei
Vice President
Margaret Marino
Vice President
Jason Pinkstaff
Vice President
Nancy Sacco
VP - Manufacturing
Hemant Kumar
VP - Regulatory Affairs
Lewis Gryziewicz
Browse more venture capital transactions:
Prev: 11/16/2010: NanoDetection Technology venture capital transaction
Next: 11/16/2010: SilkRoad Technology venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs